Research Keywords and Expertise
Osimertinib;Mutation;ErbB-1 Genes
Interests
Cancer cell lines; Signaling pathway; Targeted therapy; Immunotherapy; Preclinical models
Latest Publications
- Open Access Research articleOvercoming Palbociclib Resistance by Combined Treatment with PI3K/AKT/mTOR Inhibitors in Mesothelioma CellsGraziana Digiacomo, Claudia Fumarola, Daniele Cretella, Roberta Alfieri, ... Andrea CavazzoniJ. Mol. Clin. Med. 2018, 1(3), 151–156; https://doi.org/10.31083/j.jmcm.2018.03.00419Downloads92Views